how long has glp 1 been around The expanding landscape of GLP-1 medicines The Evolution of GLP-1 Users
Description
Here is the critical detail that many people miss
Lee MC, Tu YT, Lee CC, Tsai SC, Hsu HY, Tsai TY, et al
Transition phase (discontinuationwashoutstabilization): strictly implement clearance times based on drug characteristicsdiscontinue semaglutide for 2 months, tirzepatide for at least 1 month (161), and long-acting formulations like exenatide for at least 3 months (153, 158, 159, 162)

Higashijima, Y., Tanaka, T., Yamaguchi, J., Tanaka, S

We use a withinperson approach (each person is compared to their own baseline) so that we minimize differences that come from individual variability

Campbell Jonathan E, Drucker DJ
